Table 3.
AAV Vectors | Lentiviral Vectors |
---|---|
Serotypes that can specifically target hepatocytes efficiently | No specific hepatocyte targeting |
Typically nonintegrating (episomal) | Integrating into the genome |
Potential liver toxicity at high doses | High transduction efficiency of liver is difficult |
Stable viral particles | Typically unstable due to viral envelope |
Packaging capacity up to 4.7 Kb | Packaging capacity up to 8 Kb |
Prevalent pre-existing immunity in adult population |